Sustained Impairment of IFN-γ Secretion in Suppressed HIV-Infected Patients Despite Mature NK Cell Recovery: Evidence for a Defective Reconstitution of Innate Immunity
- 1 June 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 168 (11) , 5764-5770
- https://doi.org/10.4049/jimmunol.168.11.5764
Abstract
The impairment of NK cell functions in the course of HIV infection contributes to a decreased resistance against HIV and other pathogens. We analyzed the proportion of mature and immature NK cell subsets, and measured subsets of IFN-γ and TNF-α-producing NK and T cells in viremic or therapy-suppressed HIV-infected subjects, and noninfected control donors. Viremic HIV+ individuals had significantly lower proportions of mature CD3−/CD161+/CD56+ NK cells and of IFN-γ-producing NK cells compared with noninfected donors, independent of CD4+ T cell counts. HIV-infected subjects with undetectable viral load recovered mature CD3−/CD161+/CD56+ NK cells and cytotoxicity against tumor (K562) and HSV-infected target cells to percentages comparable with those of uninfected individuals, but their NK cells remained impaired in their ability to produce IFN-γ. In parallel to these ex vivo findings, in vitro NK cell differentiation of CD34-positive cord blood precursors in the presence of R5 or X4 HIV-1 resulted in the production of NK cells with a normal mature phenotype, but lacking the ability to produce IFN-γ, whereas coculture of uninfected PBMC with HIV failed to affect mature NK cell properties or IFN-γ secretion. Altogether, our findings support the hypothesis that mature NK cell phenotype may be uncoupled from some mature functions following highly active antiretroviral therapy-mediated suppression of HIV-1, and indicate that relevant innate immune functions of NK cell subsets may remain altered despite effective viral suppression following antiretroviral treatment.Keywords
This publication has 50 references indexed in Scilit:
- Low-Dose Daily Subcutaneous Interleukin-2 in Combination with Highly Active Antiretroviral Therapy in HIV + Patients: A Randomized Controlled TrialHIV Research & Clinical Practice, 2000
- Inhibition of Natural Killer Cell Cytotoxicity and Interferon γ Production by the Envelope Protein of HIV and Prevention by Vasoactive Intestinal PeptideAIDS Research and Human Retroviruses, 2000
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infectionCytometry, 1995
- Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cellsEuropean Journal of Immunology, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.The Journal of Experimental Medicine, 1992
- CD16+NK Cells Decrease in All Stages of HIV Infection Through a Selective Depletion of the CD16+CD8+CD3-SubsetAIDS Research and Human Retroviruses, 1990
- Pathogenesis of the natural killer cell deficiency in AIDSImmunology Today, 1990
- Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.The Journal of Experimental Medicine, 1986